RNA疗法:专注于神经系统中的反意义寡核酸
Betül Ertural1, Büşra Nur Çiçek1, Işıl Aksan Kurnaz1,2,3
1Gebze Technical University, Department of Molecular Biology and Genetics, 41400 Gebze Kocaeli, Turkiye.
Biomolecules & therapeutics
|June 19, 2025
概括
包括反感性寡核酸 (ASO) 在内的RNA疗法为神经系统疾病提供了新的治疗方法. 交付挑战和制造障碍正在得到解决,以释放他们的全部潜力.
科学领域:
- 生物技术是生物技术.
- 分子生物学分子生物学
- 神经科学是一个神经科学.
背景情况:
- RNA疗法彻底改变了药物发现,其在COVID-19大流行期间的作用凸显了这一点.
- 多种RNA分子 (ASOs,siRNAs,miRNAs,aptamers,mRNAs) 提供各种治疗机制.
- 神经系统疾病越来越多地成为基于RNA的治疗的目标,显示出显著的前景.
研究的目的:
- 审查当前RNA疗法在治疗神经系统疾病的现状.
- 识别关键挑战,特别是通过血脑屏障传递的关键挑战.
- 讨论基于RNA的神经治疗的新兴策略和未来方向.
主要方法:
- 对神经疾病的RNA疗法现有文献的综述.
- 分析成功的基于RNA的药物和正在进行的临床试验.
- 检查交付技术,例如纳米粒子配方.
主要成果:
- 像nusinersen和eteplirsen这样的反感性寡核酸 (ASO) 疗法已被批准用于特定的神经肌肉疾病.
- 新兴的ASO治疗方法通过减少与疾病相关的蛋白质,对亨廷顿病和ALS有希望.
- 纳米颗粒配方是提高RNA稳定性,细胞吸收和降低免疫性的关键.
结论:
- RNA疗法具有巨大的潜力,可以彻底改变神经系统疾病的治疗模式.
- 克服交付挑战,优化药理动力学和最大限度地减少非目标效应对于临床成功至关重要.
- 持续的创新和合作对于推进神经学中的RNA疗法至关重要.
相关概念视频
02:30siRNA - Small Interfering RNAs
17.0K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.0K
01:22Alzheimer's Disease: Treatment
265
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
265
01:23RNA Interference
26.5K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.5K
02:15Experimental RNAi
6.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K
01:29Drugs Affecting Neurotransmitter Synthesis
1.6K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.6K
01:23Types of RNA
66.2K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
66.2K